查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1466074

连续血糖监测系统市场：按组件、人口统计、患者类型、最终用户、分销管道 - 全球预测 2024-2030

Continuous Glucose Monitoring Systems Market by Component (Integrated Insulin Pumps, Sensors, Transmitters & Receivers), Demographics (Adult Population, Children Population), Patient Type, End User, Distribution Channel - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年连续血糖监测系统市场规模为55.4亿美元，预计2024年将达62.1亿美元，2030年将达到125.5亿美元，复合年增长率为12.37%。

连续血糖监测系统 (CGMS) 是一种先进的医疗设备，旨在定期（通常每隔几分钟、每天 24 小时、一年 365 天）提供即时血糖读数。这些系统由小型感测器组成，可将资料无线传输到专用接收器、智慧型手机、智慧型手錶或其他显示设备，使用户无需进行传统的手指血液测试即可监测血糖浓度。全球糖尿病患者数量不断增加，以及人们日益认识到连续血糖值监测优于传统血糖监测，推动了市场成长。然而，该设备的高价格和缺乏统一报销可能会限制市场渗透。由于设备校准问题和外部因素干扰导致的葡萄糖测量不准确也是一个挑战。此外，利用巨量资料和进阶分析来提高预测能力、个人化和临床结果，为市场成长创造了潜在的机会。

主要市场统计
基准年[2023] 55.4亿美元
预测年份 [2024] 62.1亿美元
预测年份 [2030] 125.5亿美元
复合年增长率（%） 12.37%

组件 在 CGM 系统中增加使用发射器和接收器进行即时血糖监测

整合胰岛素帮浦是一种根据设定的基础血糖值自动输送胰岛素的设备，并与连续血糖监测 (CGM) 系统配合使用。胰岛素帮浦根据即时血糖测量调整胰岛素输送。这项功能极大地有助于糖尿病患者血糖值的无缝管理，对于需要强化胰岛素治疗的患者和 1 型糖尿病患者尤其有用。该感测器是 CGM 系统的重要组成部分，因为它是测量皮下间质液中血糖浓度的组件。 CGM 感测器通常需要每 7 到 14 天更换一次，具体取决于型号。想要最小侵入和较长佩戴时间的患者更喜欢长寿命感测器。发送器是 CGM 系统的一部分，用于将即时血糖资料从感测器传输到接收器和智慧型装置。接收器是显示葡萄糖资料的装置。有些患者喜欢允许他们使用智慧型手机作为接收器的系统，而有些患者如果不喜欢使用智慧型设备，则喜欢专用设备。

人口统计：更有效、更侵入性的儿童用CGM 系统的持续进步

连续血糖监测 (CGM) 系统对于成年人极为重要，尤其是那些被诊断出患有第 1 型或第 2 型糖尿病的成年人。成年人需要持续准确地监测血糖值，以有效管理自己的病情并预防与糖尿病相关的急性和长期併发症。儿童用CGM 系统根据儿童人群独特的生理和生活方式要求，在尺寸、灵敏度和易用性方面进行了专门设计。这些设备可帮助父母和看护者更有效地监测和管理孩子的糖尿病，让他们安心并提高生活品质。

患者类型：CGM 系统在第 1 型糖尿病患者中的重要性日益增加：准确度高、时滞短、血糖快速变化的预测警报

由于胰臟中产生胰岛素的 β 细胞受到自体免疫破坏，1 型糖尿病患者依赖外部胰岛素。连续血糖监测（CGM）系统为这群人提供了便利，也是血糖浓度管理的重要工具。这些患者需要即时资料来准确调整胰岛素剂量。 CGM 系统比传统血糖监测具有显着优势，可以详细了解血糖趋势，从而更好地控制血糖并降低低血糖风险。 2 型糖尿病患者应监测血糖浓度，尤其是在服用磺酰尿素或Meglitinides药物时，这些药物并不总是需要胰岛素，但会增加低血糖的风险。 2型糖尿病的CGM旨在管理生活习惯，除了药物治疗外，还包括饮食和运动疗法。随着 CGM 技术变得越来越便宜，并且越来越多的证据表明它可以帮助改善未接受胰岛素治疗的患者的血糖控制，CGM 的使用在这群人中变得越来越普遍。

最终用户：具有远端资料共用功能的家庭患者越来越偏好 CGM 系统

诊断中心和诊所是连续血糖监测 (CGM) 系统部署的重要组成部分。这些设施通常是出现糖尿病症状或需要持续监测诊断病情的患者的第一个接触点。家庭医疗保健是 CGM 系统快速成长的领域，因为越来越多的糖尿病患者更喜欢在舒适的家中管理糖尿病。这些设备非常方便，可以进行连续监测，而无需频繁拜访您的医疗保健提供者。加护病房(ICU) 是一个至关重要的环境，病患需要随时密切监测，包括血糖浓度。 ICU CGM 系统需要可靠并与其他监测设备集成，以全面了解患者的健康状况。

区域洞察

以美国和加拿大为中心的美洲地区是 CGM 系统的强大市场，并得到高购买力和采用最新技术的成熟医疗保健系统的支持。美国和加拿大在CGM技术领域处于领先地位，有许多公司在研究和开发新系统，该领域申请的专利数量证明了这一点。美国消费者更有可能维持健康的生活方式，并将个人健康科技融入日常生活中。大量投资和保险覆盖促进了 CGM 系统的使用，使公众更容易使用它们。欧盟（EU）国家对 CGM 系统表现出强劲需求，该系统得到广泛认可，促进糖尿病生活方式管理，并得到有利的保险报销方案的支持。欧盟的医疗设备产业受到严格监管，确保产品品质和安全的高标准。德国、法国和英国等国家是实施 CGM 系统的领先国家。中东地区，特别是波湾合作理事会（GCC）国家，人均医疗保健支出较高，并且正在迅速采用先进的医疗保健技术。由于糖尿病盛行率不断上升以及人们对糖尿病的认识不断提高，亚太地区对 CGM 系统的需求正在迅速增长。用于健康监测的可穿戴技术的日益普及表明亚太地区消费者对方便且非侵入式医疗保健设备的广泛需求。

FPNV定位矩阵

FPNV定位矩阵对于评估连续血糖监测系统市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对连续血糖监测系统市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告在以下方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4. 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.连续血糖监测系统市场的市场规模与预测是多少？

2.在连续血糖监测系统市场的预测期间内，有哪些产品、细分市场、应用和领域需要考虑投资？

3.连续血糖监测系统市场的技术趋势和法规结构是什么？

4.连续血糖监测系统市场主要供应商的市场占有率为何？

5. 进入血糖连续监测系统市场合适的型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球糖尿病患者数量不断增加
      • 增加对 CGM 系统的监管核准
      • 提高 CGM 系统在家庭医疗保健中的采用率
    • 抑制因素
      • CGM 设备副作用的发生与准确性限制
    • 机会
      • 技术进步和 CGM 系统意识的提高
      • 对非侵入性治疗方法和潜在未确诊患者群体的偏好增加
    • 任务
      • 报销和严格监管问题
  • 市场区隔分析
    • 组件：提高 CGM 系统中发送器和接收器的利用率，以实现即时血糖监测
    • 人口统计：儿童CGM 系统的持续进步使其更有效且侵入性更小
    • 患者类型：CGM 系统在第 1 型糖尿病患者中的重要性日益增加。高精度、最小延迟时间以及针对快速血糖值变化的预测警报
    • 最终用户：具有远端资料共用功能的CGM系统越来越受到家庭患者的青睐
  • 市场趋势分析
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法规结构分析
  • 客户客製化

第六章连续血糖监测系统市场：依组成部分

  • 集成胰岛素泵
  • 感应器
  • 发送器和接收器

第七章按人口统计的连续血糖监测系统市场

  • 成年人口
  • 儿童人口

第八章连续血糖监测系统市场（依病患类型）

  • 1型糖尿病
  • 2型糖尿病

第九章连续血糖监测系统市场：依最终用户分类

  • 诊断中心和诊所
  • 家庭保健
  • 加护病房

第10章连续血糖监测系统市场：按分销管道

  • 向机构投资者出售
  • 零售销售

第十一章美洲连续血糖监测系统市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太连续血糖监测系统市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲/中东/非洲连续血糖监测系统市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争场景分析
    • Civionix 的 GS1 连续血糖监测系统获得 CE 标誌
    • Dexcom 针对美国人推出新的 CGM，针对不使用胰岛素的糖尿病患者
    • 美国FDA核准Abbott 的 Freestyle Libre 2 和 Freestyle Libre 3 感测器与自动胰岛素给药系统集成

第15章竞争组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-43676CF422F8

[191 Pages Report] The Continuous Glucose Monitoring Systems Market size was estimated at USD 5.54 billion in 2023 and expected to reach USD 6.21 billion in 2024, at a CAGR 12.37% to reach USD 12.55 billion by 2030.

Continuous Glucose Monitoring Systems (CGMS) are advanced medical devices designed to provide real-time glucose readings at regular intervals, typically every few minutes, 24/7. These systems comprise a small sensor that transmits the data wirelessly to a display device, which could be a dedicated receiver, a smartphone, or a smartwatch, enabling the user to monitor their glucose levels without the requirement of traditional fingerstick blood tests. The growing preponderance of diabetes across the globe and the rising awareness of the benefits of continuous glucose monitoring over traditional blood glucose monitoring are driving the market growth. However, devices' high prices and lack of uniform reimbursement can limit market penetration. Inaccuracies in glucose readings due to device calibration issues or interference from external factors also pose a challenge. Furthermore, leveraging big data and advanced analytics to improve predictive capabilities, personalization, and clinical outcomes creates potential opportunities for market growth.

KEY MARKET STATISTICS
Base Year [2023] USD 5.54 billion
Estimated Year [2024] USD 6.21 billion
Forecast Year [2030] USD 12.55 billion
CAGR (%) 12.37%

Component: Increasing utilization of transmitters & receivers in CGM systems for real-time glucose monitoring

Integrated insulin pumps are devices that deliver insulin automatically based on the set basal rate and work in conjunction with continuous glucose monitoring (CGM) systems. They adjust the insulin delivery based on real-time glucose readings. This feature greatly contributes to the seamless management of blood glucose levels in diabetes patients, especially useful for those with intensive insulin therapy needs or those with Type 1 diabetes. Sensors are a crucial part of CGM systems, as they are the components that measure levels of glucose in the interstitial fluid beneath the skin. CGM sensors typically require changing every 7 to 14 days, depending on the model. Patients who desire minimal intrusion and longer wear times prefer sensors with extended life spans. The transmitter is the part of the CGM system that sends real-time glucose data from the sensor to a receiver and smart device. The receiver is the device that displays the glucose data. Some patients prioritize a system that allows the use of their own smartphone as a receiver, whereas others prefer a dedicated device if they are not comfortable using smart devices.

Demographics: Ongoing advancements in children CGM systems to make it more effective and less invasive

Continuous Glucose Monitoring (CGM) systems are crucial for the adult population, especially those diagnosed with Type 1 or Type 2 diabetes. Adults require consistent and accurate monitoring of their blood glucose levels to manage their condition effectively and to prevent acute and long-term complications associated with diabetes. CGM systems for children are designed with special considerations for size, sensitivity, and ease of use, owing to the unique physiological and lifestyle requirements of the pediatric population. These devices help parents and caregivers monitor and manage their child's diabetes more effectively, providing peace of mind and improved quality of life.

Patient Type: Rising significance of CGM system in Type 1 diabetes patient for high accuracy, minimal lag time, and predictive alerts for rapid glucose changes

Patients with Type 1 diabetes rely on external insulin because of the autoimmune destruction of the insulin-producing beta cells in the pancreas. Continuous Glucose Monitoring (CGM) systems for this group provide convenience and crucial tools for the management of glucose levels. These patients need real-time data to adjust insulin doses accurately. CGM systems offer significant advantages over traditional blood glucose monitoring, providing detailed insights into glucose trends, which results in better glycemic control and reduction of hypoglycemia risk. Type 2 diabetes patients might not always require insulin but still need to monitor their glucose levels, especially if they are on sulfonylureas and meglitinides, which increase the risk of hypoglycemia. CGM for Type 2 diabetes is geared towards lifestyle management, including diet and exercise, alongside medication. The use of CGM is progressively becoming more common in this group as the technology becomes more affordable and as evidence mounts that it can help improve glycemic control in non-insulin-treated patients.

End User: Growing preference of CGM systems by home patients with remote data sharing capabilities

Diagnostic centers and clinics represent a significant segment for the deployment of Continuous Glucose Monitoring (CGM) systems. These facilities often serve as the initial point of contact for patients experiencing symptoms of diabetes and for those who require ongoing monitoring for their diagnosed condition. Home healthcare represents a rapidly growing segment for CGM systems, as an increasing number of patients with diabetes prefer to manage their condition in the comfort of their own homes. These devices offer convenience and allow for continuous monitoring without the need to visit a healthcare provider frequently. Intensive Care Units (ICUs) are critical settings wherein patients require constant and close monitoring, including for their glucose levels. CGM systems in ICUs must be highly reliable and capable of integrating with other monitoring equipment to ensure a holistic view of a patient's health status.

Regional Insights

The Americas, led by the United States and Canada, show a strong market for CGM systems, aided by higher purchasing power and well-established healthcare systems implementing the latest technologies. The United States & Canada are prominent in CGM technology, with numerous companies researching and developing new systems, evident from a high number of patents filed in this domain. Consumers in the United States have shown an inclination towards maintaining healthy lifestyles, integrating personal health technology with everyday living. There is significant investment and insurance coverage that promotes the use of CGM systems, making them more accessible to the population. European Union countries demonstrate a robust demand for CGM systems, broadly supported by widespread awareness, a push for lifestyle management of diabetes, and favorable insurance reimbursement scenarios. The European Union's medical device sector is tightly regulated, ensuring high standards of product quality and safety. Countries including Germany, France, and the UK are leaders in the adoption of CGM systems. The Middle East, particularly the Gulf Cooperation Council (GCC) countries, has high per capita healthcare spending and is rapidly adopting advanced technologies in healthcare. Asia Pacific is undergoing a surge in the demand for CGM systems due to the increasing prevalence of diabetes and heightened awareness about the disease. The rising popularity of wearable technology for health monitoring indicates a broad consumer need for convenient and non-intrusive healthcare devices in the APAC region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Continuous Glucose Monitoring Systems Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Continuous Glucose Monitoring Systems Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Continuous Glucose Monitoring Systems Market, highlighting leading vendors and their innovative profiles. These include A. Menarini Diagnostics s.r.l, Abbott Laboratories, AgaMatrix Inc. by I-Sens Inc., Ascensia Diabetes Care Holdings AG, Dexcom, Inc., F. Hoffmann-La Roche Ltd., Insulet Corporation, Johnson & Johnson Services, Inc., Medtronic PLC, Medtrum Technologies Inc., Nemaura Medical Inc., Novo Nordisk A/S, NXP Semiconductors N.V., Senseonics Holdings Inc., Sibionics, STMicroelectronics N.V., Tandem Diabetes Care, Inc., Texas Instruments Incorporated, and Ypsomed Holding AG.

Market Segmentation & Coverage

This research report categorizes the Continuous Glucose Monitoring Systems Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Component
    • Integrated Insulin Pumps
    • Sensors
    • Transmitters & Receivers
  • Demographics
    • Adult Population
    • Children Population
  • Patient Type
    • Type 1 Diabetes
    • Type 2 Diabetes
  • End User
    • Diagnostic Centers & Clinics
    • Home Healthcare
    • ICUs
  • Distribution Channel
    • Institutional Sales
    • Retail Sales
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Continuous Glucose Monitoring Systems Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Continuous Glucose Monitoring Systems Market?

3. What are the technology trends and regulatory frameworks in the Continuous Glucose Monitoring Systems Market?

4. What is the market share of the leading vendors in the Continuous Glucose Monitoring Systems Market?

5. Which modes and strategic moves are suitable for entering the Continuous Glucose Monitoring Systems Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing Number of Incidence of Diabetic Patients Globally
      • 5.1.1.2. Growing Regulatory Approvals for the CGM Systems
      • 5.1.1.3. Growing Adoption Rate of CGM Systems in Home Healthcare
    • 5.1.2. Restraints
      • 5.1.2.1. Occurrence of Adverse Effects and Limited Accuracy of CGM Devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological Advancements and Increased Awareness of CGM Systems
      • 5.1.3.2. Rising Preferences for Non-invasive Methods and Potential Undiagnosed Patient Population
    • 5.1.4. Challenges
      • 5.1.4.1. Reimbursement and Stringent Regulatory Issues
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Component: Increasing utilization of transmitters & receivers in CGM systems for real-time glucose monitoring
    • 5.2.2. Demographics: Ongoing advancements in children CGM systems to make it more effective and less invasive
    • 5.2.3. Patient Type: Rising significance of CGM system in Type 1 diabetes patient for high accuracy, minimal lag time, and predictive alerts for rapid glucose changes
    • 5.2.4. End User: Growing preference of CGM systems by home patients with remote data sharing capabilities
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis
  • 5.9. Client Customization

6. Continuous Glucose Monitoring Systems Market, by Component

  • 6.1. Introduction
  • 6.2. Integrated Insulin Pumps
  • 6.3. Sensors
  • 6.4. Transmitters & Receivers

7. Continuous Glucose Monitoring Systems Market, by Demographics

  • 7.1. Introduction
  • 7.2. Adult Population
  • 7.3. Children Population

8. Continuous Glucose Monitoring Systems Market, by Patient Type

  • 8.1. Introduction
  • 8.2. Type 1 Diabetes
  • 8.3. Type 2 Diabetes

9. Continuous Glucose Monitoring Systems Market, by End User

  • 9.1. Introduction
  • 9.2. Diagnostic Centers & Clinics
  • 9.3. Home Healthcare
  • 9.4. ICUs

10. Continuous Glucose Monitoring Systems Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Institutional Sales
  • 10.3. Retail Sales

11. Americas Continuous Glucose Monitoring Systems Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Continuous Glucose Monitoring Systems Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Continuous Glucose Monitoring Systems Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Sibionics obtains CE Mark for GS1 continuous glucose monitoring system
    • 14.3.2. Dexcom targets Americans with new CGM aimed at non-insulin-using diabetics
    • 14.3.3. U.S. FDA Clears Abbott's Freestyle Libre 2 and Freestyle Libre 3 Sensors for Integration with Automated Insulin Delivery Systems

15. Competitive Portfolio

  • 15.1. Key Company Profiles
  • 15.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET RESEARCH PROCESS
  • FIGURE 2. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET DYNAMICS
  • FIGURE 7. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 26. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY INTEGRATED INSULIN PUMPS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY INTEGRATED INSULIN PUMPS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SENSORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SENSORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TRANSMITTERS & RECEIVERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TRANSMITTERS & RECEIVERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ADULT POPULATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ADULT POPULATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CHILDREN POPULATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CHILDREN POPULATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DIAGNOSTIC CENTERS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DIAGNOSTIC CENTERS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ICUS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ICUS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY INSTITUTIONAL SALES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY INSTITUTIONAL SALES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY RETAIL SALES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY RETAIL SALES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 45. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 46. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 53. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 54. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 55. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 56. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 57. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 58. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 59. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 60. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 61. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 62. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 63. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 64. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 65. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 66. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 67. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 68. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 69. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 70. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 71. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 72. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 73. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 74. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 75. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 76. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 77. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 80. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 81. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 82. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 83. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 84. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 85. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 86. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 87. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 88. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 89. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 90. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 91. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 92. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 93. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 94. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 95. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 96. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 97. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 98. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 99. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 100. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 101. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 102. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 103. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 104. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 117. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 118. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 119. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 120. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 121. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 124. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 125. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 126. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 127. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 128. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 129. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 130. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 131. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 132. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 133. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 134. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 135. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 136. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 137. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 138. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 139. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 140. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 141. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 142. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 143. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 144. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 145. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 146. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 147. INDONESIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 148. INDONESIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 149. INDONESIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 150. INDONESIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 151. INDONESIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 152. INDONESIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 153. INDONESIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 154. INDONESIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 155. INDONESIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 156. INDONESIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 157. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 158. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 159. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 160. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 161. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 162. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 163. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 164. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 165. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 166. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 167. MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 168. MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 169. MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 170. MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 171. MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 174. MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 175. MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 176. MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 177. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 178. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 179. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 180. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 181. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 182. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 183. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 184. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 185. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 186. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 187. SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 188. SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 189. SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 190. SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 191. SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 192. SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 193. SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 194. SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 195. SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 196. SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 197. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 198. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 199. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 200. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 201. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 204. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 205. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 206. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 207. TAIWAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 208. TAIWAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 209. TAIWAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 210. TAIWAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 211. TAIWAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 212. TAIWAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 213. TAIWAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 214. TAIWAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 215. TAIWAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 216. TAIWAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 217. THAILAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 218. THAILAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 219. THAILAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 220. THAILAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 221. THAILAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 222. THAILAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 223. THAILAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 224. THAILAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 225. THAILAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 226. THAILAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 227. VIETNAM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 228. VIETNAM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 229. VIETNAM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 230. VIETNAM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 231. VIETNAM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 232. VIETNAM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 233. VIETNAM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 234. VIETNAM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 235. VIETNAM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 236. VIETNAM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 249. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 250. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 251. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 252. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 253. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 254. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 255. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 256. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 257. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 258. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 259. EGYPT CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 260. EGYPT CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 261. EGYPT CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 262. EGYPT CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 263. EGYPT CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 264. EGYPT CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 265. EGYPT CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 266. EGYPT CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 267. EGYPT CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 268. EGYPT CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 269. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 270. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 271. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 272. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 273. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 274. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 275. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 276. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 277. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 278. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 279. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 280. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 281. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 282. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 283. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 284. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 285. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 286. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 287. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 288. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 289. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 290. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 291. GERMANY CONTINUOUS GLUC